Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_00543 |
| Species: | Homo sapiens |
| Position : | chr16:120000-121400 |
| Year: | 2021 |
| Title: | A gain-of-function single nucleotide variant creates a new promoter which acts as an orientation-dependent enhancer-blocker |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | pancreatic ductal adenocarcinoma |
| PMID: | 34155213 |
| MONDO: | MONDO:0005147 |
| Tissue: | Pancreas |
| Tissue Ontology ID: | UBERON:0001264 |
| Cell Source: | CAPAN1 |
| CVCL ID: | CVCL_0026 |
| Cell Type: | pancreatic ductal adenocarcinoma cell |
| Cell Ontology ID: | CL:0000066 |
| Experiment Type: | Enhancer activity assay, Chromatin interaction assay |
| High Throughput Method: | ChIP-seq, ATAC-seq, RNA-seq, 3C-seq |
| Low Throughput Method: | ChIP-RT-qPCR, qRT-PCR |
| Target gene : | HBA1 |
| TF name : | GATA1; KLF1; TAL1 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|